Kabelo Mokgalaboni
Overview
Explore the profile of Kabelo Mokgalaboni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mashaba G, Phoswa W, Lebelo S, Choma S, Maimela E, Mokgalaboni K
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941702
Diabetes mellitus [DM) is a fast-increasing non-communicable disease in South Africa, with a prevalence of 11.3%. The present study aimed to longitudinally investigate the association of carotid intima-media thickness [CIMT)...
2.
Mokgalaboni K
Metabol Open
. 2025 Jan;
25:100348.
PMID: 39876902
The prevalence of cardiometabolic diseases is rising, and this is fuelled by inflammation, which tends to be worse in individuals with vitamin D (VD) deficiency. While non-steroidal anti-inflammatory interventions are...
3.
Strauss K, Phoswa W, Mokgalaboni K
Viruses
. 2025 Jan;
17(1).
PMID: 39861817
Pregnant women living with HIV (PWLWHIV) are at an increased risk of developing obstetrics complications such as pre-eclampsia (PE). Antiretroviral therapy (ART) remains the standard treatment for PWLWHIV and non-pregnant...
4.
Molapo D, Mokgalaboni K, Phoswa W
Healthcare (Basel)
. 2025 Jan;
13(1.
PMID: 39791692
Background: HIV is a global health issue, with the highest number of infected individuals found in sub-Saharan Africa. The coexistence of HIV with depression is a huge challenge. This study...
5.
Mokgalaboni K, Mashaba R, Phoswa W, Lebelo S
Nutrients
. 2024 Dec;
16(23).
PMID: 39683570
Controlling hyperglycemia and inflammation in type 2 diabetes (T2D) remains an important approach to control diabetes. The use of phytochemicals found in natural herbs has been investigated widely, and there...
6.
Nkhumeleni Z, Phoswa W, Mokgalaboni K
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596339
Type 2 diabetes (T2D) is characterised by insulin resistance and leads to hyperglycaemia. Its prevalence and associated complications continue to rise exponentially, despite the existence of pharmaceutical drugs, and this...
7.
Mashaba R, Phoswa W, Maimela E, Lebelo S, Modjadji P, Mokgalaboni K
BMJ Open
. 2024 Nov;
14(11):e087496.
PMID: 39521468
Objectives: Carotid intima-media thickness (CIMT) is a measurement for subclinical atherosclerosis and has been associated with overall cardiovascular diseases, especially in type 2 diabetes mellitus (T2DM). We aimed to assess...
8.
Mokgalaboni K, Phoswa W, Mokgalabone T, Dlamini S, Ndhlala A, Modjadji P, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456704
The global prevalence of cardiovascular diseases (CVDs), including dyslipidemia and atherosclerosis, is rising. While pharmacological treatments for dyslipidemia and associated CVDs exist, not all individuals can afford them, and those...
9.
Mashaba G, Phoswa W, Mokgalaboni K
J Cardiovasc Dev Dis
. 2024 Sep;
11(9).
PMID: 39330333
Background: The effect of statins on CIMT progression and C-reactive protein (CRP) in T2DM patients is widely reported. However, some studies demonstrated no effect of statins on CIMT and CRP...
10.
Mokgalaboni K, Mashaba G, Phoswa W, Lebelo S
Nutr Diabetes
. 2024 Apr;
14(1):22.
PMID: 38649347
Background: The beneficial effects of folate have been observed under different conditions, but the available evidence on inflammation and reduction of cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM)...